Arginine

Arginine

SCHEMBL7359381

CNCC(=O)O.N=C(N)NCCC[C@H](N)C(=O)O.N=C(N)NCCC[C@H](NS(=O)(=O)Cc1ccccc1)C(=O)O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
TMPRSS11D O60235 11/20 0.41
F2 P00734 5/20 0.41
F10 P00742 5/20 0.41
PLG P00747 5/20 0.41
TMPRSS2 O15393 2/20 0.40
ITGB3 P05106 5/20 0.40
ITGA2B P08514 3/20 0.40
ITGAV P06756 2/20 0.38
TGM2 P21980 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sarcosine SCHEMBL8800822 0.95 TMPRSS11D (0.43) SLC1A3SLC1A2SLC1A1TMPRSS11DF2
Arginine SCHEMBL7364644 0.89 ITGB3 (0.40) SLC1A3SLC1A2SLC1A1TMPRSS11DF2
SCHEMBL8799340 0.87 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1TMPRSS11DF2
SCHEMBL8597124 0.87 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1TMPRSS11DF2
Arginine SCHEMBL7359770 0.83 ITGB3 (0.40) F2ITGB3ITGA2BITGAVMMP1
Arginine SCHEMBL5598764 0.79 OTC (0.46)
SCHEMBL18419482 0.78 F10 (0.47) TMPRSS11DF2F10PLGITGB3
Arginine SCHEMBL17164594 0.75 AKR1B1 (0.45) SLC1A3SLC1A1
Arginine SCHEMBL17164595 0.75 AKR1B1 (0.45) SLC1A3SLC1A1
Arginine SCHEMBL7428963 0.75 GRIK1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6025472-A PEPTIDE ALDEHYDES WHICH ARE POTENT INHIBITORS OF FACTOR XA, USEFUL AS THERAPEUTIC AGENTS FOR DISEASE STATES IN MAMMALS CHARACTERIZED BY ABNORMAL THROMBOSIS CORVAS INTERNATIONAL, INC. (US) 2000-02-15 US disclosed
US-5696231-A ANTICOAGULANTS; CARDIOVASCULAR DISORDERS CORVAS INTERNATIONAL, INC. (US) 1997-12-09 US disclosed
WO-1996019493-A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa CORVAS INTERNATIONAL, INC. (US) 1996-06-27 WO disclosed